DUBLIN--(BUSINESS WIRE)--The "Global Nuclear Medicine Market: Analysis By Product Type, By Diagnostic Nuclear Medicine Type, By Therapeutic Nuclear Medicine Type, By Indication, By Region, By Country (2019 Edition): Opportunities and Forecast (2013-2023)" report has been added to ResearchAndMarkets.com's offering.
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Nuclear Medicine Market.
The report analyzes the Nuclear Medicine Market By Product (Therapeutic, Diagnostic), By Diagnostics (SPECT, PET), By Therapeutics (Alpha Emitters, Beta Emitters, Brachytherapy) and By Indication (Cardiovascular Disorders, Oncological Disorders, Neurological Disorders, Others).
The Nuclear Medicine Market has been analyzed By Region (North America, Europe, Asia Pacific, Rest of the World) and By Country (U.S., Canada, France, Germany, India, China, Japan and Brazil) for the historical period of 2013-2017 and the forecast period of 2018-2023.
According to the report, the global market is projected to display a robust growth represented by a CAGR of 10.07% during 2018-2023.
The indication segment of Oncological disorders has been witnessing growth at a noteworthy rate over the past few years backed by increased prevalence of cancer, presence of technical advance PET and SPECT equipment to perform treatment, rising number of nuclear centers.
Amongst the regions, North America accounts for the largest regional share in the global nuclear medicine market in 2018. Key factors driving the robust growth rate of North America region include well developed healthcare infrastructure, favorable regulatory reforms, rising prevalence of chronic ailment such as cardiovascular disorders, neurological disorders etc. in the region.
Topics Covered
1. Research Methodology
2. Executive Summary
3. Strategic Recommendations
4. Nuclear Medicine Market Overview
5. Global Nuclear Medicine: Growth and Forecast
5.1 By Value (2013-2017)
5.2 By Value (2018-2023)
6. Global Nuclear Medicine Market: By Indication
6.1 Global Nuclear
Medicine Market-By Product Type: Breakdown(%)
6.2 Global Diagnostic
Nuclear Medicine Market Overview
6.3 Global Therapeutic Nuclear
Medicine Market Overview
7. Global Nuclear Medicine Market: By Therapeutic Type
7.1 Global
Nuclear Medicine Market: By Therapeutic Type: Breakdown(%)
7.2
Global Beta Emitters Nuclear Medicine Market Overview
7.3 Global
Alpha Emitters Nuclear Medicine Market Overview
7.4 Global
Brachytherapy Nuclear Medicine Market Overview
8. Global Nuclear Medicine Market:By Diagnostic Type
8.1 Global
Nuclear Medicine Market:By Diagnostic Type: Breakdown(%)
8.2 Global
SPECT Nuclear Medicine Market Overview
8.3 Global PET Nuclear
Medicine Market Overview
9. Global Nuclear Medicine Market:By Indication
9.1 Global Nuclear
Medicine Market:By Indication: Breakdown(%)
9.2 Global Nuclear
Medicine For Oncological Disorders Market
9.3 Global Nuclear
Medicine For Cardiovascular Disorders Market
9.4 Global Nuclear
Medicine For Neurological Disorders Market
9.5 Global Nuclear
Medicine For Other Disorders Market
10. Global Nuclear Medicine Market: Regional Analysis
10.1 Global
Nuclear Medicine Market, By Region: Breakdown (%)
10.2 North
America Nuclear Medicine Market: An Analysis
10.3 North America
Nuclear Medicine Market: Segment Analysis
10.4 North America
Nuclear Medicine Market: Country Analysis (U.S. and Canada)
10.5
Europe Nuclear Medicine Market: An Analysis
10.6 Europe Nuclear
Medicine Market: Segment Analysis
10.7 Europe Nuclear Medicine
Market: Country Analysis (Germany, France, Rest of Europe)
10.8
Asia Pacific Nuclear Medicine Market: An Analysis
10.9 Asia Pacific
Nuclear Medicine Market: Segment Analysis
10.10 Asia Pacific
Nuclear Medicine Market: Country Analysis (India, China Japan & Rest of
Asia Pacific)
10.11 Rest of World Nuclear Medicine Market: An
Analysis
10.12 Rest of World Nuclear Medicine Market: Segment
Analysis
10.13 Rest of World Nuclear Medicine Market: Country
Analysis (Brazil & Others)
11. Market Dynamics
11.1 Drivers
11.2 Challenges
12. Market Trends
13. Porter's Five Forces Analysis-Nuclear Medicine Market
14. SWOT Analysis-Nuclear Medicine Market
15. Supply Chain Analysis Nuclear Medicine Market
16. Policy and Regulatory Landscape
17. Competitive Landscape
18. Company Profiles
18.1 Eckert & Ziegler
18.2 Advanced
Accelerator Applications
18.3 Cardinal Health
18.4 3B
Pharmaceuticals
18.5 Jubilant Life Sciences
18.6 Curium
18.7
Lantheus Holdings
18.8 Bracco Imaging
For more information about this report visit https://www.researchandmarkets.com/research/5d4rvw/global_nuclear?w=4
